The infectious profiles of anti-tumor necrosis factor agents in a Thai population: A retrospective study a the university-based hospital

International Journal of Rheumatic Diseases

Volumn 12, Issue 2, 2009, Pages 118-124

  Suwannalai, Parawee ^a   Auethavekiat, P ^a   Udomsubpayakul, U ^a   Janvitayanujit, S ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Anti tumor necrosis factor ; AntiTNF ; Infection

Indexed keywords

ACICLOVIR; ADEFOVIR; AUROTHIOMALATE; AZATHIOPRINE; CIPROFLOXACIN; CYCLOSPORIN; ETANERCEPT; ETHAMBUTOL; INFLIXIMAB; ISONIAZID; LAMIVUDINE; LEFLUNOMIDE; METHOTREXATE; MYCOPHENOLIC ACID; OFLOXACIN; PREDNISOLONE; PYRAZINAMIDE; RIFAMPICIN; SALAZOSULFAPYRIDINE; VANCOMYCIN;

ADULT; AGED; ANKYLOSING SPONDYLITIS; ARTICLE; BACTERIAL INFECTION; BEHCET DISEASE; CINCA SYNDROME; COMORBIDITY; CROHN DISEASE; DERMATOMYOSITIS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENTERITIS; FEMALE; HEPATITIS B VIRUS; HERPES ZOSTER; HUMAN; INCIDENCE; INFECTION; INFECTION RATE; JUVENILE RHEUMATOID ARTHRITIS; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; OCCULT INFECTION; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; REITER SYNDROME; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SKIN INFECTION; SPONDYLOARTHROPATHY; THAILAND; THORAX RADIOGRAPHY; TREATMENT DURATION; TREATMENT INDICATION; TUBERCULOSIS; UNDIFFERENTIATED SPONDYLOARTHROPATHY; UNIVERSITY HOSPITAL; VIRUS ACTIVATION; VIRUS INFECTION; VIRUS REPLICATION;

AGED; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, JUVENILE RHEUMATOID; ARTHRITIS, PSORIATIC; ARTHRITIS, REACTIVE; ARTHRITIS, RHEUMATOID; BACTERIAL INFECTIONS; FEMALE; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HIV INFECTIONS; HOSPITALS, UNIVERSITY; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULIN G; INFECTION; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; RETROSPECTIVE STUDIES; RHEUMATIC DISEASES; SPONDYLITIS, ANKYLOSING; THAILAND; TUBERCULOSIS, PULMONARY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 67749102110     PISSN: 17561841     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1756-185X.2009.01393.x     Document Type: Article

References (13)

1. Singh G, Ramey DR, Rausch PL, et al. (1999) Serious infection in rheumatoid arthritis: Relationship to immunosuppressive use. Arthritis Rheum 42, S242.
2. Doran MF, Crowson CS, Pond GR, et al. (2002) Frequency of infection in patients with rheumatoid arthritis compared with controls: A population-based study. Arthritis Rheum 46, 2287-93.
3. Etanercept (Enbrel) package insert. (2004) Thousand Oaks, CA, USA, Amgen Inc. & Wyeth-Ayerst Pharmaceuticals.
4. FDA Briefing Document (2009 March 16) Update in the TNF-alpha blocking agents [online]. Available from URL. http://www.fda.gov/ohrms/dockets/ac/ 03/briefing/3930b1.htm. [2009 March 16 Accessed].
5. Kumar A (2006) Experience with anti-tumor necrosis factor-α therapy in India. APLAR J Rheumatol 9, 136-41.
6. Huang F, Wang L, Zhang J-L, et al. (2006) Risk of tuberculosis in a Chinese registry of rheumatoid arthritis and ankylosing spondylitis for tumor necrosis factor-α antagonists. APLAR J Rheumatol 9, 170-4.
7. Takeuchi T, Tatsuki Y, Nogami Y, et al. (2008) Post-marketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis. Ann Rheum Dis 67, 189-94.
8. Keane J, Gershon S, Wise RP, et al. (2001) Tuberculosis associated with infliximab a tumor necrosis factor alpha-neutralizing agent. N Eng J Med 345, 1098-104.
9. Beglingera C, Dudlerb J, Mottetc C, et al. (2007) Screening for tuberculosis infection before initiation of anti TNF-a, therapy. SWISS Med Wkly 37, 621-2.
10. Calabrese LH, Zein N, Vassilopoulos D (2006) Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic disease: assessment and preventive strategies. Ann Rheum Dis 65, 983-9.
11. Anelli MG, Diletta DT, Manno C, et al. (2005) Improvement of renal function and disappearance of hepatitis B, virus DNA, in a patient with rheumatoid arthritis and renal amyloidosis following treatment with infliximab. Arthritis Rheum 52, 2519-20.
12. Zein N (2005) Etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis C, virus infection: A phase 2 randomized, double-blind placebo-controlled study. J Hepatol 42 (3), 315-22.
13. Feletar M, Brockbank JE, Schentag CT, et al. (2004) Treatment of refractory psoriatic arthritis with infliximab: A 12 month observational study of 16 patients. Ann Rheum Dis 63, 156-61.